Barriers and facilitators of exploiting the potential of value-added medicines-Reference-Cited by-同舟云学术

Barriers and facilitators of exploiting the potential of value-added medicines

Published:2020-04-29 Issue:3 Volume:20 Page:229-236
ISSN:1473-7167
Container-title:Expert Review of Pharmacoeconomics & Outcomes Research
language:en
Short-container-title:Expert Review of Pharmacoeconomics & Outcomes Research

Author:

Petykó Zsuzsanna Ida¹²,Inotai András¹²^ORCID,Holtorf Anke-Peggy³^ORCID,Brixner Diana⁴,Kaló Zoltán¹²^ORCID

Affiliation:

1. Center for Health Technology Assessment, Semmelweis University, Budapest, Hungary

2. Syreon Research Institute, Budapest, Hungary

3. Health Outcomes Strategies, Basel, Switzerland

4. Pharmacotherapy Outcomes Research Center, Department of Pharmacotherapy, University of Utah, Salt Lake City, UT, USA

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Health Policy,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737167.2020.1758558

Reference51 articles.

1. Switching from Originator Brand Medicines to Generic Equivalents in Selected Developing Countries: How Much Could Be Saved?

2. Comparing Generic Drug Markets in Europe and the United States: Prices, Volumes, and Spending

3. Need for Multicriteria Evaluation of Generic Drug Policies

4. Societal value of generic medicines beyond cost-saving through reduced prices

5. Medicines for Europe – Value added medicines [Internet]. Brussels, Belgium; [cited 2019 Aug 20]. Available from: https://www.medicinesforeurope.com/value-added-medicines/did-you-know/

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Facilitators and Barriers of Incremental Innovation by Fixed Dose Combinations in Cardiovascular Diseases;Journal of Cardiovascular Development and Disease;2024-06-21

2. Pharmaceutical innovativeness index: methodological approach for assessing the value of medicines – a case study of oncology drugs;Expert Review of Pharmacoeconomics & Outcomes Research;2024-06-13

3. The Next Horizon of Drug Development: External Control Arms and Innovative Tools to Enrich Clinical Trial Data;Therapeutic Innovation & Regulatory Science;2024-03-25

4. Measurement and valuation of the attributes of innovation of healthcare technologies: a systematic review;Journal of Medical Economics;2022-11-15

5. Characterizing attributes of innovation of technologies for healthcare: a systematic review;Journal of Medical Economics;2022-11-11